摘要
目的 观察血栓通联合尤瑞克林治疗中老年人急性脑梗死的临床疗效。方法 将120例急性脑梗死患者随机分为两组,治疗组60例在常规治疗基础上给予0.9%氯化钠注射液250 ml＋血栓通400 mg静脉滴注,0.9%氯化钠注射液100 ml＋尤瑞克林0.15PNA单位静脉滴注,每天1次;对照组60例在常规治疗基础上仅给予0.9%氯化钠注射液250 ml＋血栓通400 mg静脉滴注,每天1次,连续治疗2周,观察两组患者治疗前后神经功能缺损评分及临床疗效。结果 治疗组总有效率为91.7%,对照组总有效率71.7%,治疗组明显优于对照组（P〈0.01）;神经功能缺损评分治疗后明显高于治疗前,差异有统计学意义（P〈0.05）。结论 血栓通联合尤瑞克林治疗中老年人急性脑梗死临床疗效显著,具有协同作用,安全性高,副作用少,值得临床推广使用。
Objective To observe the effect of Xueshuantong combined with Urinary Kallidinogenase on acute cerebral infarction in middle-aged and aged people.Methods 120 patients with acute cerebral infarction were randomly divided into two groups,the treatment group was given 400mg Xueshuantong with 0.15PNA of Urinary Kallidinogenase,while the control group was only given 400mg Xueshuantong.After treatment for 2 weeks,the nerve function deficit score and the curative effect were compared between two groups.Results The curative effect of treatment group and control group was 91.7% and 71.7%,respectively.The nerve function deficit score in two groups was decreased than before treatment,the difference between two groups was significant （P〈0.05）.Conclusion The effect of Xueshuantong combined with Urinary Kallidinogenase in treatment of acute cerebral infarction in middle-aged and aged people was confirmed with high safety and low side effects,which worthy of clinical application.
出处
《中国基层医药》
CAS
2013年第9期1296-1297,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
血栓通
尤瑞克林
脑梗死
Xueshuantong
Urinary Kallidinogenase
Brain infarction
